137 related articles for article (PubMed ID: 19920104)
1. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG; Eijsink JJ; Ten Hoor KA; Roossink F; Hollema H; Arts HJ; Pras E; Maduro JH; Reyners AK; de Bock GH; Wisman GB; Schuuring E; van der Zee AG
Clin Cancer Res; 2009 Dec; 15(23):7389-97. PubMed ID: 19920104
[TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
3. Akt expression may predict favorable prognosis in cholangiocarcinoma.
Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
[TBL] [Abstract][Full Text] [Related]
4. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
[TBL] [Abstract][Full Text] [Related]
5. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
8. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
[TBL] [Abstract][Full Text] [Related]
9. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
[TBL] [Abstract][Full Text] [Related]
10. Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Mendiola C; Alonso L; Alba E; Lanzós E
Oncology; 2009; 76(2):133-41. PubMed ID: 19174612
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
12. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
13. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
[TBL] [Abstract][Full Text] [Related]
14. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Sotoca A; Pérez-Ruiz E; Lanzós E
Am J Clin Oncol; 2011 Aug; 34(4):395-400. PubMed ID: 20859196
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
[TBL] [Abstract][Full Text] [Related]
16. Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Hammarsten P; Karalija A; Josefsson A; Rudolfsson SH; Wikström P; Egevad L; Granfors T; Stattin P; Bergh A
Clin Cancer Res; 2010 Feb; 16(4):1245-55. PubMed ID: 20145160
[TBL] [Abstract][Full Text] [Related]
17. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2005 Aug; 27(2):317-25. PubMed ID: 16010411
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
19. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Di Lorenzo G; Tortora G; D'Armiento FP; De Rosa G; Staibano S; Autorino R; D'Armiento M; De Laurentiis M; De Placido S; Catalano G; Bianco AR; Ciardiello F
Clin Cancer Res; 2002 Nov; 8(11):3438-44. PubMed ID: 12429632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]